�������

News from ������� Langone Health

World Trade Center Dust Linked To Breast Cancer Development, ������� Langone Health Study Finds. (Washington Square (NY) News)

The (9/11) Researchers at �����о��� Langone Health’s Perlmutter Cancer Center found that people exposed to dust and fumes from the 9/11 attacks on the World Trade Center are likely to show genetic abnormalities associated with breast cancer, with senior study author Alan A. Arslan, MD, associate professor, Departments of Obstetrics and Gynecology, and Population Health, stating, “These findings help explain why World Trade Center rescuers and survivors are more prone to certain types of cancer, including breast cancer,” and emphasizing the need for further research on DNA methylation in populations exposed to harmful chemicals.

������� Langone Health Performs Fully Robotic Lung Transplant. (Healthcare Purchasing News)

(9/11) Surgeons at �����о��� Langone Health have performed the first fully robotic lung transplant in the nation, making it only the third program globally to use a robotic system for lung transplant surgery; Stephanie H. Chang, MD, associate professor, Department of Cardiothoracic Surgery, who led the surgery, described the approach as “overall less invasive…compared to the traditional open chest procedure.” �����о��� Langone Health’s Transplant Institute performed 76 lung transplants in 2023, being rated best in the nation for lung survival after transplant and getting patients off the waitlist fastest by the Scientific Registry of Transplant Recipients.

Also reporting is WINS (9/11).

������� Langone Health Opens New Ambulatory Care Center Near Penn Station. (NYBiz Daily)

(9/11) �����о��� Langone Health has opened an 18,000-square-foot medical facility, �����о��� Langone Medical Associates – Penn District, at 360 West 31st Street, offering services in internal medicine, family medicine, endocrinology, gastroenterology, orthopedic surgery, podiatry, spine surgery, sports medicine, and urology, featuring 25 exam rooms, 3 procedure rooms, and imaging services. “Penn District further expands access to �����о��� Langone Health’s award-winning and consistently high standard of care,” said Andrew W. Brotman, MD, executive vice president and vice dean for clinical affairs and strategy, and chief clinical officer, while Vicki Match Suna, AIA, executive vice president and vice dean for real estate development and facilities, added, “We’ve taken a respectful and innovative design approach with this new space, as we do with all of our new facilities, incorporating an abundance of natural light and prioritizing the use of sustainable materials in furnishings throughout.”

Daily Briefing: Meet The Recipient Of The First Whole-Eye Transplant. (Nature)

(9/10) Aaron James, an electrical lineman who lost an eye and much of his face in an electrical accident, who at ������� Langone Health became the first person to receive a face transplant that included a whole eye, has gone a year since the surgery where a transplanted piece of carotid artery supplies blood to the donated eye, which responds to light but is not expected to restore his sight.

Inside Abbott’s Upcoming Clinical Trial For Treatment-Resistant Depression. (Healthcare Brew)

(9/10) Abbott has announced a new double-blind, randomized clinical trial of its Infinity deep brain stimulation (DBS) system for treatment-resistant depression, following a similar trial by St. Jude Medical in 2008, and researchers from Emory University School of Medicine found DBS of the subcallosal cingulate region beneficial for depression severity, while health systems such as ������� Langone Health offer this experimental treatment, though it is not FDA-approved for this purpose.

How To Feel Better At Every Age: Tips For Fitness, Diet, Stress Relief. (TODAY)

(9/11) Natalie E. Azar, MD, clinical associate professor, Department of Medicine, Division of Rheumatology, “joins TODAY to share healthy habits you can start now to feel better as you age such as focusing on calcium in younger years, scheduling movement once a day and finding stress lowering activities.”

New Prostate Cancer Medication ‘Shows Promise’ In Treating Aggressive Disease, Study Finds. (Fox News)

(9/10) Researchers from Flinders University and the University of South Australia have identified the novel drug CDKI-73 as a potential treatment for drug-resistant prostate cancer, with the study published in the British Journal of Cancer reporting that it “defies conventional therapies.” Marc K. Siegel, MD, clinical professor, Department of Medicine, Division of General Internal Medicine and Clinical Innovation, commented on the study, saying, “In this new study, an inhibitor of CDK 9 (CDKI-73) was found to inhibit growth and lead to death in human prostate cancer cells in the laboratory, and also in animals and models.”

In a separate embedded video, (9/11) Marc K. Siegel, MD, clinical professor, Department of Medicine, Division of General Internal Medicine and Clinical Innovation discusses whether weight-loss drugs are safe for children on ‘The Big Money Show.”